This is a preview of subscription content, log in via an institution to check access.
Reference
Peral C, et al. Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain. ClinicoEconomics and Outcomes Research : 26 Sep 2016. Available from: URL: https://dx.doi.org/10.2147/CEOR.S111646
Rights and permissions
About this article
Cite this article
Fesoterodine with fast dose escalation good choice for OAB. PharmacoEcon Outcomes News 763, 16 (2016). https://doi.org/10.1007/s40274-016-3429-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3429-y